RICHMOND, Va.--(BUSINESS WIRE)--Owens & Minor, Inc. (NYSE: OMI) (the “Company”) announced the completion of the sale of its Products & Healthcare Services (P&HS) segment and the Owens & Minor brand to Platinum Equity and is renaming the publicly traded parent company Accendra Health, Inc. “Today's announcement marks an inflection point in the strategic transformation of Owens & Minor into Accendra Health, a leading nationwide pure play home based care platform. The completio.
LONDON, UK / ACCESS Newswire / December 31, 2025 / Orosur Mining Inc. ("Orosur" or "the Company") (AIM:OMI)(TSXV:OMI), a minerals explorer and developer with projects in Colombia and Argentina, advises that, following the Admission of 666,664 common shares of no par value ("Common Shares") on 16 December 2025 pursuant to the exercise of options by consultants of the Company, as announced on 15 December 2025, the Company has 392,689,176 Common Shares in issue. There were no warrants exercised and therefore no Common Shares issued during December from the Company's block listing.
Owens and Minor (NYSE: OMI - Get Free Report) and Senestech (NASDAQ: SNES - Get Free Report) are both small-cap medical companies, but which is the superior business? We will compare the two companies based on the strength of their dividends, valuation, institutional ownership, analyst recommendations, earnings, risk and profitability. Volatility and Risk Owens and Minor has
RICHMOND, Va.--(BUSINESS WIRE)--Owens & Minor, Inc. (NYSE: OMI) (“the Company”) today announced that it will change its name to Accendra Health, Inc. with an anticipated effective date of December 31, 2025. The name change affects only the name of the parent corporation and is intended to better reflect the Company's strategic direction and future organizational focus as a leader in the home-based care market. The Company will continue to use and operate under the Apria and Byram Healthcare.
Owens & Minor, Inc. (OMI) Presents at Citi Annual Global Healthcare Conference 2025 Transcript
RICHMOND, Va.--(BUSINESS WIRE)--Owens & Minor, Inc. (NYSE: OMI) announced today that members of its management team are scheduled to participate in two upcoming investor conferences. Citi 2025 Global Healthcare Conference On Tuesday, December 2, 2025, Ed Pesicka, the Company's President and Chief Executive Officer, and Will Parrish, the Company's Vice President of Strategy, Corporate Development, & Investor Relations, are scheduled to participate in a fireside chat at 2:30 P.M. ET and h.
Orosur Mining Inc. -Notice of Annual and Special Meeting LONDON, UK / ACCESS Newswire / November 21, 2025 / Orosur Mining Inc. ("Orosur" or "the Company") (TSX-V:OMI)(AIM:OMI) the minerals explorer and developer currently operating in Colombia and Argentina announces that copies of the Company's Notice of Annual and Special Meeting ("AGM"), including the Management Information Circular and proxy forms have been posted to shareholders. Copies are also available on the website at: https://www.orosur.ca A link to the PDF version of the Notice of AGM is also available here: http://www.rns-pdf.londonstockexchange.com/rns/4570I_1-2025-11-20.pdf The AGM will be held on 17 th December 2025 at 12.30pm GMT (UK local time) at the offices of SP Angel Corporate Finance LLP, Prince Frederick House, 35-39 Maddox Street, London, W1S 2PP, England.
Exercise of RSUs and options LONDON, UK / ACCESS Newswire / November 4, 2025 / Orosur Mining Inc. ("Orosur" or the "Company") (TSXV:OMI)(AIM:OMI) announces the following: The Company has issued 4,358,332 Common Shares ("Shares") representing 1.13% of the Company's current issued share capital, following the exercise of 3,123,332 RSUs and 1,280,000 options by directors and consultants of the Company. All of the directors will be retaining their Shares and not selling after exercise.
Owens & Minor, Inc. ( OMI ) Q3 2025 Earnings Call October 30, 2025 5:00 PM EDT Company Participants Will Parrish Edward Pesicka - President, CEO & Director Jonathan Leon - Executive VP, CFO & Corporate Treasurer Perry Bernocchi - Executive VP & CEO of Patient Direct Segment Conference Call Participants Daniel Christopher Clark - Leerink Partners LLC, Research Division Kevin Caliendo - UBS Investment Bank, Research Division Daniel Grosslight - Citigroup Inc., Research Division Presentation Operator Good day, and thank you for standing by. Welcome to Owens & Minor's Third Quarter 2025 Earnings Conference Call.
RICHMOND, Va.--(BUSINESS WIRE)--Owens & Minor, Inc. (NYSE: OMI) today reported financial results for the third quarter ended September 30, 2025. Unless otherwise noted, the results herein reflect the Company's continuing operations, which primarily represent what was previously the Patient Direct segment and certain functional operations. “Our recent announcement on the sale of our Products & Healthcare Services segment is another meaningful step in our strategy to pivot our focus to th.
